After 1 year on the GFD , the mean mucosal villous height : crypt depth values increased ( P < .001 ) , levels of celiac-associated antibodies decreased ( P < .003 ) , and gastrointestinal symptoms improved to a greater extent than in patients on gluten-containing diets ( P = .003 ) .